Exploring the Multifunctional Characteristics of the Stem Cell Factor Receptor (KIT / SF Receptor)

Published by ANT BIO PTE. LTD.

1. Concept

The Stem Cell Factor Receptor (also known as KIT, CD117, or SCFR) is a type III receptor tyrosine kinase (RTK) that acts as a master regulator of cell survival, proliferation, differentiation, migration, and metabolism. Upon binding its ligand SCF (Stem Cell Factor), KIT dimerizes and triggers a cascade of downstream signaling events essential for hematopoiesis, germ cell development, melanocyte function, and gastrointestinal motility. Dysregulation of KIT drives multiple cancers, inherited disorders, and inflammatory diseases, making it a core target for basic research and precision therapy.

2. Research Frontiers

Recent advances in KIT research include:

• High-resolution structural characterization of KIT–SCF binding and dimerization.
• Identification of oncogenic KIT mutations in GIST, mastocytosis, and AML.
• Development of next‑generation tyrosine kinase inhibitors (TKIs), antibody–drug conjugates (ADCs), bispecific antibodies, and PROTACs.
• Elucidation of epigenetic and post‑transcriptional control of KIT expression.
• KIT‑targeted cell therapies including CAR‑T and immune‑recruiting modalities.

3. Research Significance

KIT is indispensable across development, physiology, and disease:

• Supports hematopoietic stem cell maintenance and immune cell maturation.
• Governs spermatogenesis, follicle maturation, and germ cell migration.
• Drives melanoblast development and pigmentation.
• Maintains interstitial cells of Cajal (ICC) for gut peristalsis.
• Serves as a diagnostic marker and therapeutic target in GIST, leukemia, and mastocytosis.

Understanding KIT regulation enables improved diagnostics, prognostic biomarkers, and targeted cancer treatments.

4. Structure, Signaling, Physiology, and Disease

4.1 Structure and Signal Transduction Mechanism

KIT is a 976‑amino‑acid transmembrane glycoprotein (145–160 kDa) with:

• Five extracellular Ig‑like domains (domain 3: SCF binding; domain 5: structural disulfide bond).
• A single transmembrane helix.
• An intracellular tyrosine kinase domain.

SCF binding induces 1:1 dimerization and autophosphorylation at Tyr823, fully activating kinase function. Activated KIT recruits SH2/PTB‑domain adaptors and initiates four major signaling axes:

• RAS–RAF–MEK–ERK: proliferation
• PI3K–AKT–mTOR: survival and metabolism
• JAK–STAT: cell fate
• PLCγ–DAG–PKC: migration and secretion

Signaling is tightly controlled by Cbl‑mediated ubiquitination and SHP1/2‑dependent dephosphorylation.

[Image Location: Epigenetic Modifications of ESR and SF-1 Receptors in Endometriosis]

4.2 Physiological Functions

Hematopoietic System

KIT maintains hematopoietic stem and progenitor cells (HSPCs) and supports lineage commitment. It is a key diagnostic marker (CD117).

Reproductive System

KIT–SCF signaling regulates spermatogenesis, oocyte maturation, and primordial germ cell migration.

Melanocyte Development

KIT controls melanoblast migration, survival, and melanin production via MITF. Loss‑of‑function causes piebaldism.

Gastrointestinal Function

KIT is required for ICC development and slow‑wave electrical activity that drives gut motility.

4.3 Dysregulation and Disease Associations

Oncogenic Mutations

Activating KIT mutations drive ~85% of GISTs (most commonly exon 11), as well as subsets of AML and melanoma.

Mastocytosis

The KIT D816V mutation is present in ~90% of systemic mastocytosis cases and confers imatinib resistance.

Developmental Disorders

Loss‑of‑function mutations cause piebaldism, anemia, and immunodeficiency.

Fibrotic & Inflammatory Diseases

KIT contributes to pulmonary fibrosis, chronic urticaria, and transplant rejection.

4.4 Advances in KIT‑Targeted Therapies

• TKIs: Imatinib, midostaurin, and avapritinib for mutation‑specific cancers.
• ADCs: LOP628 and other targeted cytotoxins.
• Bispecific antibodies: CD117×CD3 for leukemia.
• Cell therapy: KIT‑directed CAR‑T.
• Allosteric inhibitors & PROTACs: overcome resistance.

4.5 Research Tools Enabled by ANT BIO PTE. LTD.

High‑quality reagents are essential to study KIT expression, activation, mutations, and signaling:

• Western Blot (WB): Detect total and phosphorylated KIT.
• Immunohistochemistry (IHC‑P): Quantify KIT in tumor and tissue sections.
• Flow cytometry: Immunophenotype HSPCs and cancer cells (CD117).
• ELISA: Quantify soluble KIT or SCF in biofluids.
• Recombinant proteins: Support binding, kinase, and drug‑screening assays.

5. Our Mission at ANT BIO PTE. LTD.

ANT BIO PTE. LTD. accelerates breakthroughs in developmental biology, oncology, and precision medicine by providing highly validated KIT antibodies, recombinant proteins, and detection kits. Our tools enable consistent, reproducible results in basic research, biomarker validation, and drug discovery.

6. Featured KIT / SF Receptor–Related Products

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights